China Medical Technologies received approval to market its high intensity focused ultrasound (HIFU) tumor therapy system in Korea. The medical device was approved for the indications of liver cancer, pancreatic cancer and uterine fibroids. The approval sent the stock higher, once again.  More details...

Stock Symbol: (NSDQ: CMED)